CAPTRUST Financial Advisors’s Trulieve Cannabis TRLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.48M Buy
+135,802
New +$1.38M ﹤0.01% 1524
2022
Q3
– Sell
-11,309
Closed -$130K – 4749
2022
Q2
$130K Buy
11,309
+233
+2% +$2.68K ﹤0.01% 2018
2022
Q1
$233K Buy
11,076
+3,815
+53% +$80.3K ﹤0.01% 1621
2021
Q4
$189K Buy
7,261
+5,766
+386% +$150K ﹤0.01% 1682
2021
Q3
$40K Buy
1,495
+10
+0.7% +$268 ﹤0.01% 2736
2021
Q2
$56K Buy
1,485
+785
+112% +$29.6K ﹤0.01% 2448
2021
Q1
$32K Buy
+700
New +$32K ﹤0.01% 2714

Other funds holding TRLV

CAPTRUST Financial Advisors's TRLV Position: Q3 2026 in Review

CAPTRUST Financial Advisors opened a new position in Trulieve Cannabis (TRLV) in Q3 2026: 135,802 shares worth $1.48M. The stake represents ﹤0.01% of the portfolio and ranks #1524 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in TRLV as recently as Q2 2022.

CAPTRUST Financial Advisors first reported a position in TRLV in Q1 2021 and has held it in 7 quarters since. 157 funds tracked by Wall St. Rank hold TRLV as of Q3 2026.

  • CAPTRUST Financial Advisors held 135,802 shares of Trulieve Cannabis worth $1.48M as of Q3 2026.
  • Trulieve Cannabis was a new CAPTRUST Financial Advisors position in Q3 2026.
  • Trulieve Cannabis made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q3 2026, its #1524 holding.
  • CAPTRUST Financial Advisors first reported a position in Trulieve Cannabis in Q1 2021 and has held it in 7 quarters since.
  • 157 funds tracked by Wall St. Rank held Trulieve Cannabis as of Q3 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.